U.S. Sen. Johnson: Leads colleagues in demanding answers from Dr. Califf and Dr. Fauci
WASHINGTON — Last week, U.S. Sen. Ron Johnson (R-Wis.), along with U.S. Sen. Ted Cruz (R-Texas), U.S. Rep. Andy Biggs (R-Ariz.) and U.S. Rep. Chip Roy (R-Texas), sent a letter to the U.S. Food and Drug Administration (FDA) Commission Dr. Robert Califf and the Director of the National Institute of Allergy and Infectious Diseases (NIAID) Dr. Anthony Fauci seeking answers to why certain drugs used in the treatment of COVID-19 have not received Emergency Use Authorization (EUA). The treatment, ZYESAMI has successfully saved the lives of more than 20 COVID-19 patients under the Right to Try Act. The members wrote,